Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
about
Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@ast
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@en
type
label
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@ast
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@en
prefLabel
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@ast
Expression of EIF5A2 associate ...... d with induction chemotherapy.
@en
P2093
P2860
P1433
P1476
Expression of EIF5A2 associate ...... ed with induction chemotherapy
@en
P2093
Bao-Zhu Zhang
Hai-Qiang Mai
Meng-Qing Li
Pei-Yu Huang
Ting-Ting Zeng
Wen-Feng Hua
Xiaojiao Ban
Ying-Hui Zhu
P2860
P2888
P356
10.1186/S12885-016-2714-2
P407
P577
2016-08-22T00:00:00Z
P6179
1000059278